Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDF) Short Interest Up 7.1% in August

Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDFGet Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 15th, there was short interest totalling 828,400 shares, a growth of 7.1% from the July 31st total of 773,400 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Hua Medicine (Shanghai) Price Performance

Shares of HUMDF opened at C$0.20 on Thursday. The firm has a fifty day moving average price of C$0.20 and a 200-day moving average price of C$0.35. Hua Medicine has a 12-month low of C$0.20 and a 12-month high of C$0.20.

Hua Medicine (Shanghai) Company Profile

(Get Free Report)

Hua Medicine (Shanghai) Ltd. operates as a drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D.

Further Reading

Receive News & Ratings for Hua Medicine (Shanghai) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hua Medicine (Shanghai) and related companies with MarketBeat.com's FREE daily email newsletter.